Risk of Atrial Fibrillation After Atrial Flutter Ablation: Impact of AF History, Gender, and Antiarrhythmic Drug Medication
Authors:
- Brembilla‐ PerrotBPBrembilla‐ Perrot
- BéatriceBÉBéatrice
- Nicolas GirerdNGNicolas Girerd
- 21 April 2014
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 25 (8) , 813-820
Abstract
Antiarrhythmic Drug and Ablation of Atrial Flutter: Introduction: Atrial fibrillation (AF) and flutter (AFL) are frequently associated. We assessed the frequency and identified the predictors of AF occurrence after AFL ablation.Methods and Results: A total of 1,121 patients referred for AFL ablation were followed for a mean duration of 2.1 ± 2.7 years. Antiarrhythmic drugs were stopped after ablation in patients with no AF prior to ablation, or continued otherwise. A total of 356 patients (31.7%) had a history of AF prior to AFL ablation. Patients with AF prior to ablation were more likely to be females (OR = 1.35, CI = 1.00–1.83, P = 0.05). After ablation, 260 (23.2%) patients experienced AF. In the multivariable model, AF prior to ablation (OR = 1.90, CI = 1.42–2.54, P < 0.001) and female gender (OR = 1.77, CI = 1.29–2.42, P < 0.001) were associated with a higher risk of AF after ablation. In patients without prior AF, class I antiarrhythmics and amiodarone prior to AFL ablation were independently associated with higher risk of AF after ablation (OR = 2.11, CI = 1.15–3.88, P = 0.02 and OR = 1.60, CI = 1.08–2.36, P = 0.02, respectively). In patients who experienced AF after ablation, 201/260 (77.3%) had a CHA2DS2‐VASc ≥1. Two patients with AF prior to ablation had a stroke during the follow‐up whereas none of the patients without AF prior to ablation had a stroke.Conclusions: AF occurrence after AFL ablation is frequent (>20%), especially in patients with a history of AF, in female patients, and in patients treated with class I antiarrythmics/amiodarone prior to AFL. Since most patients who experience AF after AFL ablation have a CHA2DS2‐VASc ≥1, the decision to stop anticoagulants after ablation should be considered on an individual basis.Keywords
This publication has 31 references indexed in Scilit:
- Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: The Belgrade atrial fibrillation studyInternational Journal of Cardiology, 2012
- Atrial fibrillation after typical atrial flutter ablation: a long-term follow-upJournal of Cardiovascular Medicine, 2011
- Atrial Flutter Versus Atrial Fibrillation in a General Population: Differences in Comorbidities Associated With Their Respective OnsetClinical Medicine & Research, 2009
- Interventional Electrophysiology in Patients With Congenital Heart DiseaseCirculation, 2007
- Incidence of Atrial Fibrillation Post‐Cavotricuspid Isthmus Ablation in Patients with Typical Atrial Flutter: Left‐Atrial Size as an Independent Predictor of Atrial Fibrillation RecurrenceJournal of Cardiovascular Electrophysiology, 2007
- Different Clinical Courses and Predictors of Atrial Fibrillation Occurrence After Transisthmic Ablation in Patients with Preablation Lone Atrial Flutter, Coexistent Atrial Fibrillation, and Drug Induced Atrial FlutterPacing and Clinical Electrophysiology, 2004
- Ablation of Isthmus Dependent Atrial Flutter:Pacing and Clinical Electrophysiology, 2004
- Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin?Cardiovascular Research, 2002
- Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective studyEuropean Heart Journal, 2002
- Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutterThe American Journal of Cardiology, 1993